David S. Perlin, Ph.D. - Public Health Research Institute

David S. Perlin, Ph.D.
Executive Director and Professor
Public Health Research Institute
Rutgers-New Jersey Medical School
Director, Rutgers Regional Biocontainment
Fellow, New York Academy of Sciences
Dr. David S. Perlin, PhD is Executive Director of the
Rutgers-New Jersey Medical School’s Public Health Research Institute (PHRI), a
73 year old specialized center for global infectious diseases research. He is also
Director of the new Rutgers Regional Biocontainment Laboratory, one of thirteen
NIH-designated national centers, and a Professor of Microbiology and Molecular
Genetics. Dr. Perlin helped establish PHRI as a leading tuberculosis and
opportunistic infections research organization. His primary expertise is in fungal
infections, mechanisms of antifungal drug resistance, and rapid diagnosis of
opportunistic drug resistant bacterial and fungal pathogens in high-risk patients.
He has published more than 190 papers and book chapters and has co-authored
two books. His laboratory is supported by grants from the NIH, pharma and
biotech sectors. He is on the editorial board of several scientific journals and
serves on the Board of Directors of the Aaron Diamond AIDS Research Center,
and Scientific/Medical Advisory Boards for the CLSI, LIFE, pharma and biotech
companies, and PinnacleCare. He is also a member of the New York City
Department of Health and Mental Hygiene Advisory Panel on Bioterrorism and
Emerging Infections, the Executive Committee of the Northeast Biodefense
Center, and Steering Committee for Microbiology, Immunology & Infectious
Diseases of the New York Academy of Sciences
Dr. Perlin earned an AB degree from Brandeis University in 1976 and a Ph.D. from
Cornell University in 1980. He pursued postdoctoral studies at the Yale University
School of Medicine and the University of Rochester School of Medicine and
Dentistry. Dr. Perlin joined PHRI in 1985; he was named Scientific Director in
1992, President in 2005, and Director of the new UMDNJ Center in 2006. He was
appointed Professor of Microbiology and Molecular Genetics in 2003 and
Executive Director of PHRI and the Rutgers Regional Biocontainment Laboratory
in 2010. Dr. Perlin was named a Fellow of the New York Academy of Sciences in
2005, and a Visiting Professor at the University of Manchester, UK in 2009.
Rutgers-New Jersey Medical School
At the International Center for Public Health
TEL: (973) 854-3200; FAX: (973) 854-3101; WWW.PHRI.ORG
EMAIL: [email protected]